DocGo (NASDAQ:DCGO – Get Free Report) is expected to be announcing its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect the company to post earnings of ($0.0975) per share and revenue of $75.35 million for the quarter. Parties may review the information on the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Thursday, August 13, 2026 at 5:00 PM ET.
DocGo (NASDAQ:DCGO – Get Free Report) last issued its earnings results on Monday, May 11th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.10). DocGo had a negative net margin of 62.23% and a negative return on equity of 44.09%. The company had revenue of $75.55 million for the quarter, compared to analyst estimates of $72.48 million. On average, analysts expect DocGo to post $-0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
DocGo Trading Up 0.6%
NASDAQ DCGO opened at $0.65 on Wednesday. DocGo has a 1-year low of $0.45 and a 1-year high of $1.78. The company has a market capitalization of $64.41 million, a PE ratio of -0.34 and a beta of 0.99. The firm’s fifty day simple moving average is $0.59 and its 200-day simple moving average is $0.65.
Analyst Upgrades and Downgrades
Read Our Latest Stock Report on DocGo
Institutional Inflows and Outflows
Several hedge funds have recently modified their holdings of the business. Cerity Partners LLC bought a new position in shares of DocGo during the 2nd quarter valued at $37,000. Strs Ohio acquired a new position in DocGo during the first quarter worth $76,000. Engineers Gate Manager LP bought a new position in DocGo during the second quarter valued at about $52,000. Neuberger Berman Group LLC bought a new position in DocGo during the fourth quarter valued at about $29,000. Finally, Public Employees Retirement System of Ohio acquired a new stake in shares of DocGo in the fourth quarter worth about $40,000. Institutional investors and hedge funds own 56.44% of the company’s stock.
DocGo Company Profile
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.
Featured Stories
- Five stocks we like better than DocGo
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
